Biohit Oyj (BIOBV):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Biohit Oyj (BIOBV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6626
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biohit Oyj (Biohit) is a biotechnology company that offers research and early diagnosis processing products. The company’s products comprise acetaldehyde binding products, diagnostic tests, dysbiosis test, microplate readers and washers, monoclonal antibodies, and pipettes. It targets therapeutic areas such as gastric cancer, gastroesophageal reflux disease and colorectal cancer, among others. Biohit provides analyses of non-alcoholic and alcoholic beverages and carcinogenic acetaldehyde in foodstuff. The company promotes evaluation and adoption of Biohit’s diagnostic tests and analysing systems. It also offers tests for the diagnosis of lactose intolerance and helicobacter pylori infection. The company operates in Finland, Italy and the UK. Biohit is headquartered in Helsinki, Finland.

Biohit Oyj (BIOBV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biohit Oyj, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biohit Oyj, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Biohit Oyj, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biohit Oyj, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Biohit Oyj, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Biohit Oyj, Medical Equipment, Deal Details 10
Asset Purchase 10
Biohit Acquires Rights To UFT300 Test From Advanced Biomedical Systems For US$0.5 Million 10
Partnerships 11
Biohit HealthCare (Hefei) Enters into Licensing Agreement with Biohit 11
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 12
Biohit Enters into Distribution Agreement with Pooyandegan Pezeshki Pardis 13
Biohit and Onsite Diagnostic Labs Enter into Distribution Agreement 14
Biohit Enters into Distribution Agreement with Genetic Analysis 15
Biohit Enters Into Distribution Agreement With Dynex Technologies 16
Biohit Forms Joint Venture with Anhui Wisdom-Win Investment 17
Ferring Pharma Enters Into Distribution Agreement With Biohit Healthcare For PreventID CalScreen 18
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 19
Biohit Enters Into Distribution Agreement With Hefei Medicine For GastroPanel Test 20
Biohit Enters Into Distribution Agreement With Fisher Scientific For Diagnostic Products 21
Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 22
Acquisition 23
Biohit Acquires 18% Stake in Genetic Analysis 23
Biohit Completes Acquisition of Euroclone Gastro from Euroclone for USD1.48 Million 24
Biohit Oyj – Key Competitors 25
Biohit Oyj – Key Employees 26
Biohit Oyj – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 27
Recent Developments 28
Financial Announcements 28
Aug 22, 2018: Biohit Group half year financial report 2018 28
Feb 28, 2018: Biohit Group Financial Statement Release 2017 37
Aug 17, 2017: Biohit Group Half Year Financial Report 2017 44
Feb 20, 2017: Biohit Group Financial Statement Release 2016 49
Corporate Communications 53
Jul 30, 2018: Biohit Oyj: Management changes 53
Feb 20, 2018: Changes to Biohit Oyj’s Management Team 54
May 04, 2017: Lea Paloheimo appointed Biohit Oyj’s R&D and production director 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
Biohit Oyj, Medical Equipment, Key Facts, 2017 2
Biohit Oyj, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Biohit Oyj, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biohit Oyj, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Biohit Oyj, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biohit Oyj, Deals By Market, 2012 to YTD 2018 8
Biohit Oyj, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Biohit Acquires Rights To UFT300 Test From Advanced Biomedical Systems For US$0.5 Million 10
Biohit HealthCare (Hefei) Enters into Licensing Agreement with Biohit 11
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 12
Biohit Enters into Distribution Agreement with Pooyandegan Pezeshki Pardis 13
Biohit and Onsite Diagnostic Labs Enter into Distribution Agreement 14
Biohit Enters into Distribution Agreement with Genetic Analysis 15
Biohit Enters Into Distribution Agreement With Dynex Technologies 16
Biohit Forms Joint Venture with Anhui Wisdom-Win Investment 17
Ferring Pharma Enters Into Distribution Agreement With Biohit Healthcare For PreventID CalScreen 18
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 19
Biohit Enters Into Distribution Agreement With Hefei Medicine For GastroPanel Test 20
Biohit Enters Into Distribution Agreement With Fisher Scientific For Diagnostic Products 21
Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 22
Biohit Acquires 18% Stake in Genetic Analysis 23
Biohit Completes Acquisition of Euroclone Gastro from Euroclone for USD1.48 Million 24
Biohit Oyj, Key Competitors 25
Biohit Oyj, Key Employees 26
Biohit Oyj, Subsidiaries 27
Biohit Oyj, Joint Venture 27

List of Figures
Biohit Oyj, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Biohit Oyj, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Biohit Oyj, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Biohit Oyj, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Biohit Oyj, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biohit Oyj, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Biohit Oyj, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biohit Oyj, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Biohit Oyj (BIOBV):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PhoenixBio Co Ltd (6190):企業の財務・戦略的SWOT分析
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services including dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and blo …
  • Solargiga Energy Holdings Ltd (757):電力:M&Aディール及び事業提携情報
    Summary Solargiga Energy Holdings Ltd (Solargiga Energy), a subsidiary of Wafer Works Corp is a renewable energy equipment manufacturer that develops and markets monocrystalline silicon products. The company manufactures monocrystalline silicon solar ingots and wafers, solar cells and photovoltaic m …
  • DEPObank – Banca Depositaria Italiana SpA:企業の戦略的SWOT分析
    DEPObank - Banca Depositaria Italiana SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Chicago Bridge & Iron Company N.V.:企業の戦略・SWOT・財務情報
    Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report Summary Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析
    H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Miromatrix Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a life science company that develops regenerative medicines. The company offers MIRODERM biologic wound matrix, MIROMESH biologic matrix, liver function restoration, kidney products, diabetes treatment and cortical strut. It creates biological r …
  • Doosan Infracore Co Ltd (042670):企業の財務・戦略的SWOT分析
    Doosan Infracore Co Ltd (042670) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bharat Heavy Electricals Ltd (BHEL):企業の財務・戦略的SWOT分析
    Bharat Heavy Electricals Ltd (BHEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Theravance Biopharma Inc (TBPH):企業の財務・戦略的SWOT分析
    Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Parker Hannifin Corporation (PH)-石油・ガス分野:企業M&A・提携分析
    Summary Parker Hannifin Corporation (Parker) is a manufacturer of motion and control technologies and systems. The company offers critical motion and control solutions including fluid power systems, electromechanical controls and related components. Its products find use in various industries and ap …
  • Singapore Power Ltd:企業の戦略的SWOT分析
    Singapore Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Kukje Pharmaceutical Industry Co Ltd (002720):企業の財務・戦略的SWOT分析
    Summary Kukje Pharmaceutical Industry Co Ltd (Kukje) is a manufacturer, and distributor of pharmaceuticals, cosmetics and healthcare products. The company’s products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, other antibiotics, antifungal and antiviral agents. Kukj …
  • Trinity Industries Inc (TRN):電力:M&Aディール及び事業提携情報
    Summary Trinity Industries Inc. (Trinity) is a diversified industrial company. It produces and supplies railcars and railcar parts, inland barges, aggregates and highway products. It also manufactures tank containers, steel parts and structural wind towers. It also offers services such as railcar fl …
  • Barra Resources Limited:企業の戦略・SWOT・財務情報
    Barra Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Barra Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Capital Lease Aviation Limited:企業の戦略・SWOT・財務分析
    Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Lyka Labs Ltd (LYKALABS):企業の財務・戦略的SWOT分析
    Summary Lyka Labs Ltd (Lyka Labs) is a manufacturer of pharmaceutical formulations and active pharmaceutical ingredients. The company provides formulations such as lyophilized injections, topical formulations of cream, ointment, foams, gels and lotions. It offers formulation research and development …
  • Vivendi S.A.:戦略・SWOT・企業財務分析
    Vivendi S.A. - Strategy, SWOT and Corporate Finance Report Summary Vivendi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • HTC Corporation:企業のM&A・事業提携・投資動向
    HTC Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HTC Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Elekta AB (EKTA B):医療機器:M&Aディール及び事業提携情報
    Summary Elekta AB (Elekta) is a medical technology company that offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotact …
  • Alviva Holdings Ltd (AVV):企業の財務・戦略的SWOT分析
    Alviva Holdings Ltd (AVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆